



Congenital Heart Disease Takeda et alUse of quantitative analysis of remote myocardial fibrosis with
delayed-enhancement magnetic resonance imaging to predict
outcomes after surgical ventricular restoration for ischemic
cardiomyopathy
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Objective: Preserved myocardial function remote from surgical site is crucial for good outcome after surgical
ventricular restoration in ischemic cardiomyopathy. We hypothesized that left ventricular scarring untouched
by operation would negatively affect postoperative outcome.
Methods: In 15 consecutive patients (mean age 61  12 years, mean left ventricular ejection fraction 20% 
7.5%), left ventricular assessments by magnetic resonance imaging and right heart catheterization were per-
formed before and after operation. Left ventricular basal scarring remote from surgical exclusion site was quan-
tified from hyperenhancement area on preoperative delayed-enhancement magnetic resonance imaging as
percentage of fibrosis (total infarct size relative to ventricular mass).
Results:Calculated percentage of fibrosis varied from 0% to 29.9% (mean 12% 9.6%). Percentage of fibrosis
linearly correlated with significantly worse postoperative hemodynamic variables and left ventricular function
recovery: left ventricular ejection fraction (P ¼ .0005, R ¼0.79), left ventricular end-systolic volume index
(P¼ .05, R¼ 0.51), mean pulmonary arterial pressure (P¼ .004, R¼ 0.70), pulmonary capillary wedge pressure
(P ¼ .009, R ¼ 0.65), and cardiac index (P ¼ .005, R ¼0.69). At mean 30-month follow-up, 4 patients with
recurrent heart failure had significantly greater percentage of fibrosis than did those without recurrence
(19%  8.2% vs 8.8%  8.6%, P ¼ .04).
Conclusion: Amount of myocardial scarring at left ventricular base affected postoperative left ventricular func-
tion and hemodynamic improvements. Preoperative quantitative assessment of remote myocardial status with
delayed-enhancement magnetic resonance imaging may predict outcomes for patients undergoing surgical ven-
tricular restoration.Surgical ventricular restoration (SVR) is increasingly being
used as a treatment for ischemic cardiomyopathy. Several
reports, including the RESTORE (the international Recon-
structive Endoventricular Surgery returning Torsion Origi-
nal Radius Elliptical shape to the left ventricle) group
experience, have showngoodmidterm to long-term survivals
with acceptable operative mortality.1-5 Current relative con-
traindications for SVR are severe pulmonary hypertension,
right ventricular dysfunction, and diastolic dysfunction
with severe mitral regurgitation.3,4,6 Several recent studies,
however, have suggested that SVR is not necessarily contra-
indicated for patients with those presumed high surgical
risks.7-9 Although the ongoing Surgical Treatment for Ische-
mic Heart Failure trial may address open and controversial
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there is currently no consensus regarding indications for
SVR.
Preoperative assessment of myocardial status can provide
a meaningful perspective on the application of SVR. To
predict whether myocardium remains stunned or hibernat-
ing or has been irreversibly infarcted, magnetic resonance
imaging (MRI) is now gaining widespread use.2,4,9,11 Espe-
cially, delayed-enhancement MRI (DE-MRI) is an impor-
tant diagnostic tool to determine the nonfunctional
infarcted area that should be excluded with SVR.11,12 More-
over, it provides additional information regarding the
myocardial status remote from the region of planned exclu-
sion.11 Because remote myocardial asynergy directly affects
the surgical outcome,3,13 assessment of remote myocardial
status with DE-MRI may be critical in patient selection.
No study to date, however, has quantitatively investigated
how much viable remote myocardium is crucial for
a good outcome.
In this study, we focused on the amount of remote myo-
cardial fibrosis, especially left ventricular (LV) basal fibro-
sis, quantitatively assessed by DE-MRI, and evaluated the
correlation with surgical outcomes to elucidate appropriate
risk stratification.urgery c December 2008




DEF ¼ change in ejection fraction
DE-MRI ¼ delayed-enhancement magnetic
resonance imaging
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
MRI ¼ magnetic resonance imaging
NYHA ¼ New York Heart Association
PAP ¼ pulmonary arterial pressure
PCWP ¼ pulmonary capillary wedge pressure
SVR ¼ surgical ventricular restoration
MATERIALS AND METHODS
Patients
Ethical committee approval was obtained for this retrospective study,
and informed consent was obtained from all patients. We included 15 con-
secutive patients who underwent DE-MRI study for the assessment of myo-
cardial status before SVR between 2001 and 2007. The patients underwent
MRI study 4.1  1.1 weeks before the operation. Table 1 shows preopera-
tive clinical profiles of all the patients. There were 12 men and 3 women,
with a mean age of 61  11 years (42–77 years). Thirteen patients
(86.7%) were in New York Heart Association (NYHA) functional class
III or IV. SVR was performed for large anteroseptal scars (4 dyskinetic
and 11 akinetic). Seven patients had a history of another myocardial infarc-
tion in the territory of the circumflex or right coronary artery. Mean delay
from first anterior myocardial infarction to the operation was 961  950
days, and all patients had a chronic process of LV remodeling. No one
had a preoperative history of spontaneous ventricular arrhythmia.
Operations
Operative variables are shown in Table 2. All operations were performed
by a single surgeon (G.M). Conventional cardiopulmonary bypass was used
with mild hypothermia. Simultaneous mitral valve repair and coronary artery
bypass grafting (CABG) were performed during aortic crossclamping and
with antegrade and retrograde blood cardioplegia. CABG was performed
with the aim of complete revascularization with the predominant use of in-
ternal thoracic arteries. We prefer to perform SVR on the beating heart
whenever possible. The decision to perform SVR on the beating or arrested
heart was made on the basis of clamp time, concomitant procedures, and
presence of LV mural thrombus. The most important concept in our surgical
strategy for SVR is exclusion of only nonviable and noncontractile myocar-
dium. Accordingly, surgical exclusion area was precisely planned on the ba-
sis of preoperative assessment of LV wall motion and viability with MRI
(Figure 1). Nonviable tissue was determined by extent of hyperenhancement
area on DE-MRI.12 During the study period, reconstruction of the anterosep-
tal wall was performed with Dor-type procedure with a Fontan stitch, or with
septal anterior ventricular exclusion (SAVE)14 when the LV akinesis was
broad. In the SAVE cases, a longitudinal Dacron polyester fabric patch (7
3 2.5 cm) was sutured to the transitional zone to exclude broad anteroseptal
scarring without Fontan stitch, and special care was taken to create the ellip-
tical LV shape. SVR procedures were Dor-type procedures in 4 cases and
SAVE in 11. Simultaneous procedures performed during operations were
CABG in 10 cases (1–4 grafts/patient), restrictive mitral annuloplasty (2
sizes smaller than measured) with a Carpentier-Edwards Physio ring (Ed-
wards Lifesciences LLC, Irvine, Calif) for more than 2þmitral regurgitation
in 8 cases, tricuspid ring annuloplasty in 5 cases, intraventricular papillary
muscle imbrication15 in 7 cases, and maze procedure in 2 cases. Five patients
who did not undergo CABG had previously undergone revascularizationThe Journal of Thoracic and Ceither percutaneously or surgically or had no viable myocardium despite
the residual coronary stenosis. Mean cardiopulmonary bypass and aortic
crossclamp times were 185  65 and 74  32 minutes, respectively.
MRI Protocol
MRI images were acquired with a commercially available 1.5-T imager
(GE Healthcare Technologies, Waukesha, Wis) with a phased-array coil
with repeated breath-holding and retrospective electrocardiographically
triggered gating. Steady-state free precession cine images were acquired
in multiple short-axis views (every 8 mm throughout the entire LV). Tem-
poral resolution of cine images ranged from 30 to 50 ms. The myocardial
borders were planimetered on all the short-axis cine images to determine
LV function. Contrast agent (gadopentetate dimeglumine [INN gadopen-
tetic acid], 0.1–0.2 mmol/kg) was administered intravenously, and 8 to 12
DE-MRI images, depending on the cardiac size, were acquired after 10 to
15 minutes with a segmented inversion-recovery technique in the identical
planes.16 Hyperenhancement tissue on DE-MRI images was assumed to
represent scarred myocardium.
Quantitative Assessment of Myocardial Scar Tissue
We specifically evaluated the LV basal scar tissue remote from the site
of surgery. Quantification of the scarred myocardium was performed with
the two most basal DE-MRI images just beneath the aortic valve, which
represented the most basal part of the LV (Figure 2). In this study popula-
tion, there were no patients in whom anteroseptal myocardium at the
most basal part had been entirely infarcted with the transmural extent of
TABLE 1. Preoperative patient’s characteristics (n¼15)
Age (y) 61  12
Sex (male/female) 11:4
New York Heart Association functional
class III or IV (No.)
13 (86.7%)
Delay from myocardial infarction (d) 961  950 (75–5666)
Previous cardiac surgery (No.) 2 (13.3%)
Hyperlipidemia (No.) 5 (33.3%)
Hypertension (No.) 4 (26.7%)
Diabetes mellitus (No.) 4 (26.7%)
Chronic renal failure (No.) 1 (6.7%)
Mitral regurgitation grade (No.)
0 or 1 5
2 3
3 or 4 7
Type of asynergy (No.)
Dyskinetic 4
Akinetic 11




TABLE 2. Operative variables
Type of surgical ventricular restoration (No.)
Dor 4
Septal anterior ventricular exclusion 11
Coronary artery bypass grafting (No.) 10 (66.7%)
Mitral annuloplasty (No.) 8 (53.3%)
Tricuspid annuloplasty (No.) 5 (33.3%)
Maze (No.) 2 (13.3%)
Mean bypass time (min) 185  65
Mean cross clamp time (min) 74  32ardiovascular Surgery c Volume 136, Number 6 1515
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DFIGURE 1. Preoperative and postoperative long-axis delayed-enhancement magnetic resonance images in patient with anteroapical dyskinetic aneurysm.
Preoperative image shows transmural hyperenhancement area at anteroapical wall (A, arrowheads). After operation, hyperenhancement area was completely
excluded with endoventricular patch (B, arrows).hyperenhancement tissue. The most LV basal images were carefully defined
in consensus by two observers (K.T. and G.M.). To quantify the myocardial
mass of the LV, the endocardial and epicardial borders were traced for each
slice. Hyperenhancement area was defined as any region with a signal inten-
sity at least 2 SD above a reference normal myocardial region.17 The hyper-
enhancement regions were automatically contoured, and the area of
hyperenhancing tissue was calculated. DE-MRI analysis was verified by
an experienced observer (S.H.) blinded to the surgical procedure. Measure-
ment of hyperenhancement area was repeated three times in each case to
minimize the potential errors, and the mean was used as the final value.
Then the volumes of the LV wall and scarred myocardium were calculated
by adding the areas and multiplying the resulting value with slice thickness.
We expressed hyperenhancement mass as a percentage of the LVmass (per-
centage of fibrosis).
Assessments of Cardiac Function and Mitral
Regurgitation
MRIwas used to calculate LV ejection fraction (LVEF), LV end-systolic
volume index (LVESVI), and LV end-diastolic volume index. MRI study
was repeated at 3.7  2.2 weeks after the operation. Preoperative and post-
operative degrees of mitral regurgitation were quantified by means of echo-
cardiographic Doppler analysis on a 5-point scale (0 to 4þ) with almost the
same timing as MRI study. Preoperative right heart catheterization (6.8
weeks before the operation) was used to measure mean pulmonary arterial
pressure (PAP), pulmonary capillary wedge pressure (PCWP), and cardiac
index. Postoperative hemodynamic parameters were obtained at 2.2  1.0
weeks after the operation.
Neurohormonal Assessment
Serum brain natriuretic peptide was measured at the time of preoperative
and postoperative MRI studies.
Postoperative Medical Regimens
Most patients had postoperative heart failure regimens, including b-
blockers, angiotensin-converting enzyme inhibitors, or angiotension II re-
ceptor blockers, and spironolactone. Three patients who had postoperative
ventricular arrhythmia develop were treated with amiodarone.
Statistical Analysis
SPSS software (version 11.0; SPSS Inc, Chicago, Ill) was used for statis-
tical analyses. The quantitative data are presented as mean SD. Values ob-1516 The Journal of Thoracic and Cardiovascular Stained from preoperative and postoperative data were compared with the
paired t test. The unpaired t test was used to compare the groups. The con-
tinuous variables were compared with linear regression analysis.
RESULTS
Early Outcomes
All patients tolerated the operation, and 30-day mortality
was nil. Three patients required intra-aortic balloon pumping
but could be weaned in the early perioperative period. One
patient who had refractory ventricular tachycardia develop
required an implantable defibrillator in the early postopera-
tive period. Postoperative hemodynamic and functional pa-
rameters were improved significantly. NYHA functional
class improved significantly, from 3.2  0.6 preoperatively
to 1.9  0.8 postoperatively (P< .0001). Degree of mitral
regurgitation was less than grade 2 in all patients postopera-
tively and decreased significantly, from 2.0  1.5 to 0.2 
0.4 (P ¼ .002). Serum brain natriuretic peptide level de-
creased significantly, from 640  731 pg/mL to 358 
454 pg/mL (P ¼ .02). In all cases, SVR improved LVEF
and LV volumes. LV end-diastolic volume index decreased
from 169  51 mL/m2 to 105  37 mL/m2 (P< .0001),
and LVESVI decreased from 134  50 mL/m2 to 74  34
mL/m2 (P< .0001). LVEF improved from 20%  7.5%
to 31%  10% (P ¼ .0001). Mean change in ejection frac-
tion (DEF) was 10% 6.9%. Mean PAP decreased from 26
 10 mm Hg to 22  7.1 mm Hg, but this change did not
reach statistical significance (P ¼ .06). There were no signif-
icant differences between preoperative and postoperative
values of PCWP (18  7.6 mm Hg vs 15  6.8 mm Hg,
P ¼ .28) and cardiac index (2.4  0.4 L/[min $ m2] vs 2.6
 0.6 L/[min $ m2], P ¼ .28).
Distribution of Hyperenhancement Area on DE-MRI
There was no hyperenhancement area on the LV base in
2 patients with dyskinetic anteroapical aneurysm. Amongurgery c December 2008
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C
DFIGURE 2. Representative short-axis delayed-enhancement magnetic resonance images of left ventricular base in patients with anteroseptal infarction (A),
anteroseptal with posterolateral infarction (B), and anteroseptal with inferoposterior infarction (C). Myocardial scarring was clearly identified as hyperen-
hancement region (arrow).the remaining 13 patients, hyperenhancement area was
identified at the anteroseptal wall in 6 cases and at the ante-
roseptal with the lateral or inferior wall or both in 7 cases
(Figure 3). Percentage of fibrosis ranged from 0% to
29.9%, with a mean value of 12%  9.6%. In particular,
patients with a history of left main trunk occlusion (Fig-
ure 2, B) or large inferoposterior myocardial infarction
(Figure 2, C) had a larger percentage of fibrosis. At the
basal area analyzed by MRI in this study, the former group
of patients had diffuse subendocardial anteroseptal to lat-The Journal of Thoracic and Caeral scarring, whereas the latter group had near-transmural
inferoposterior scarring.
Impact of Percentage of Fibrosis on Cardiac
Function
There were statistically significant correlations between
percentage of fibrosis and preoperative mean PAP (P ¼
.0001, R ¼ 0.83) and PCWP (P ¼ .0002, R ¼ 0.82). LV
volumes (LV end-diastolic volume index P ¼ .23, LVESVI
P¼ .14), and LVEF (P¼ .15) had no significant correlationrdiovascular Surgery c Volume 136, Number 6 1517
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Dwith percentage of fibrosis. Postoperative LVEF (P¼ .0005,
R ¼0.79), LVESVI (P ¼ .05, R ¼ 0.51), mean PAP (P ¼
.004, R ¼ 0.70), PCWP (P ¼ .009, R ¼ 0.65), and cardiac
index (P ¼ .005, R ¼ 0.69) had significant correlations
with percentage of fibrosis (Figure 4).
Table 3 compares preoperative variables between the
groups with more than 10% improvement in LVEF and
those with less than 10% improvement. Patients with less
than 10% DEF (n ¼ 6) had significantly larger preoperative
percentage of fibrosis (P ¼ .002).
Impact of Percentage of Fibrosis on Recurrence of
Heart Failure
During a mean follow-up of 30 months, 2 patients died of
recurrent heart failure at 3.7 and 57 months after the opera-
tion. The heart from a patient who died earlier was examined
by pathologists (Figure 5). The analysis showed a large
scarred basal inferoposterior area, compatible with the pre-
operative MRI study. Another 2 patients were readmitted
for congestive heart failure but recovered from NYHA func-
tional class III to II after adequate medical treatment. The
others (n ¼ 11) were well and in NYHA functional class I
or II. All 4 patients with recurrent congestive heart failure
FIGURE 3. Location of myocardial scarring on LV base and percentage of
fibrosis in individual patient. AS, Anteroseptal wall; ASþI/L, anteroseptal
with inferior or lateral wall.1518 The Journal of Thoracic and Cardiovascular Swere included in the group of patients with DEF less than
10%. Table 4 shows preoperative parameters associated
with adverse postoperative outcomes tested at univariate
analysis. Only percentage of fibrosis was a statistically sig-
nificant predictor of recurrent heart failure (P¼ .04). The re-
lationship between percentage of fibrosis and postoperative
NYHA functional class is shown in Figure 6.
DISCUSSION
In this study, we focused on LV basal scar tissue remote
from the area considered for surgical exclusion by SVR
and investigated whether it affected the early and midterm
postoperative outcomes. Imaging of the remote myocardial
status is crucial when we plan SVR, because LV asynergy
is often severe and global in ischemic cardiomyopathy. Pre-
viously, Di Donato and colleagues3,13 reported that patients
with remote myocardial asynergy had a worse prognosis be-
cause of lack of recovery of regional function after SVR.
That study, however, provided no conclusive evidence to
demonstrate remote myocardial status (viable vs nonviable).
Viability assessment by inotropic stimulus (dobutamine
stress test) is helpful to determine reserved contractility of
remote segments3; however, it provides no quantitative
data about myocardial fibrosis. We specifically quantified
the degree of remote myocardial fibrosis with DE-MRI.
We found a significant correlation between percentage of
fibrosis and lesser improvement of postoperative LV systolic
function and symptoms (Figure 4). Our data indicate the ex-
tent of LV basal fibrosis is associated with postoperative
global cardiac function. Theoretically, resection of the aki-
netic or dyskinetic scar tissue and reshaping of the spherical
LV to a more elliptical shape by SVR reduces wall stress and
produces a more helical fiber orientation, which improves
regional myocardial performance in remote viable muscle.18
Various previous studies have confirmed this theoretic ben-
efit of SVR. Taniguchi and coworkers19 reported that reduc-
tion of regional afterload by LV aneurysmectomy improved
velocity of circumferential shortening in noninfarcted myo-
cardial segments. With regard to remote myocardial perfor-
mance, Dor and colleagues2 and Dor and Di Donato13
showed its importance with the centerline method on ventri-
culography. Some studies wtih MRI tagging methods have
also shown improvements in regional myocardial function
after SVR to be most marked at the base LV and in the infe-
rior wall, remote from the surgical site.20,21 Consequently,
these studies, including our own, demonstrate that residual
remote myocardial function, especially LV basal function,
generates the improvement in global LV systolic function af-
ter SVR.
Our patients underwent various surgical interventions, in-
cluding revascularization and reduction of mitral regurgita-
tion, that also improve global pump function. There are
still no conclusive data regarding the role of SVR in itself
for ischemic cardiomyopathy because of the lack ofurgery c December 2008
Takeda et al Congenital Heart DiseaseFIGURE 4. Scatter graphs showing linear regressions between percentage of fibrosis and postoperative (Post) left ventricular ejection fraction (LVEF), left
ventricular end-systolic volume index (LVESVI),mean pulmonary arterial pressure (PAP), pulmonary capillary wedge pressure (PCWP), and cardiac index (CI).A
C
Drandomized studies. The Surgical Treatment for Ischemic
Heart Failure trial may address these controversial issues
in a randomized, controlled setting.10
Interestingly, percentage of fibrosis had significant posi-
tive correlations with postoperative mean PAP and PCWP,
which were sustained even after the aggressive correction
of mitral regurgitation by restrictive annuloplasty. This find-
ing indicates the role of the elevation of LVfilling pressure as
a result of reduced compliance of the LV after SVR related to
the extent of remote myocardial fibrosis. Previous reports
have demonstrated that SVR contributed to the rise in
mean PAP by reducing compliance of the LV in some pa-
tients.22 Most recently, Menicanti and colleagues3 clearly
showed that patients with severe diastolic dysfunction had
an increased operative risk during SVR.3 In addition to the
systolic impairment, extent of infarct scarring contributed
to abnormal ventricular chamber stiffness with diastolic dys-
function in an experimental animal model of myocardial in-
farction.23Our data therefore suggest that patients with broad
LV basal scarring seen on DE-MRI may have substantial
risks with SVR in terms of diminished compliance of the LV.
In this small series, we achieved acceptable early results
with respect to improvements in LV function and functional
status and decrease in brain natriuretic peptide level. The av-
erage increase in LVEF of 10% 6.9% is similar to values
reported in other series1,3-6; however, there are still no obvi-
ous data on which patients will have meaningful recovery af-
ter SVR. In our series, 6 patients had less benefit in terms of
systolic improvement (DEF<10%). They had significantly
larger percentages of fibrosis, although their degree of pre-
operative LV remodeling was similar to that of patientsThe Journal of Thoracic and Cwith good improvement (DEF>10%; Table 3). This result
was consistent with the previous recommendation of Meni-
canti and Di Donato6 that poor basal function may be a rela-
tive contraindication for SVR. Because of poor
postoperative recovery of systolic function, patients with
poor basal function are likely to be a high-risk group, as
previous studies have demonstrated.1,3,4,6 Actually, in our
population, patients with postoperative heart failure symp-
toms had significantly higher percentage of fibrosis
(Table 4). Although our study did not have statistically suf-
ficient power to clarify a risk factor for adverse outcome be-
cause of the small number of patients, our results do imply
that remote myocardial fibrosis visible on DE-MRI could
be a key determinant in patient selection for SVR. A further
TABLE 3. Comparison of preoperative variables according to







LV end-diastolic VI (mL/m2) 162  53 176  52 .63
LV end-systolic VI (mL/m2) 125  53 144  50 .51
LV ejection fraction (%) 21%  8.7% 19%  6.4% .63
Mitral regurgitation grade 1.6  1.6 2.1  1.6 .54
Mean pulmonary arterial
pressure (mm Hg)
21  5.4 33  11 .01
Pulmonary capillary wedge
pressure (mm Hg)
14  5.4 22  7.9 .04
Cardiac index (L/[min $ m2]) 2.4  0.4 2.5  0.4 .38
Brain natriuretic peptide (pg/mL) 726  916 526  433 .63
Percentage of fibrosis 5.4%  5.2% 19%  8.5% .002
DEF, Change (improvement) in ejection fraction; LV, left ventricular; VI, volume
index.ardiovascular Surgery c Volume 136, Number 6 1519
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optimal cutoff value of percentage of fibrosis to predict late
adverse outcomes.
LIMITATIONS
There are several limitations of this study. The number of
patients was small, and selection bias is possible. Another
limitation is the lack of later imaging studies. For instance,
myocardium may take as long as 1 year to respond to coro-
nary revascularization.24 In our study, 10 of 15 patients un-
derwent CABG concurrently with SVR. Time course of
FIGURE 5. Heart specimen showing basal ventricular section 3.7 months
after operation. Note broad inferoposterior transmural infarction (black ar-
rows) consistent with findings on preoperative short-axis delayed-enhance-
ment magnetic resonance imaging (upper left inset, white arrows). A,
Anterior wall; LV, left ventricle; S, septum,RV, right ventricle; I, inferior wall.








LV end-diastolic VI (mL/m2) 154  47 206  43 .07
LV end-systolic VI (mL/m2) 119  46 174  39 .06
LV ejection fraction (%) 22  8.0 17  4.2 .22
Mitral regurgitation grade 1.7  1.6 2.3  1.7 .58
Mean pulmonary arterial
pressure (mm Hg)
24  10 30  10 .33
Pulmonary capillary wedge
pressure (mm Hg)
16  6.6 22  8.9 .16
Cardiac index (L/[min $ m2]) 2.4  0.4 2.5  0.3 .63
Brain natriuretic peptide (pg/mL) 622  794 709  552 .86
Percentage of fibrosis 8.8%  8.6% 20%  8.2% .04
CHF, Congestive heart failure; LV, left ventricular; VI, volume index.1520 The Journal of Thoracic and Cardiovascular Smyocardial recovery may have influenced postoperative
global LV function and degree of reverse LV remodeling.
Regarding the technical aspects, a variety of surgical pro-
cedures could influence outcomes. SVR is still not a standard
technique, however, and the optimal choice remains to be in-
vestigated. We agree with Suma and associates5 that the ex-
tent of visible endocardial scarring is not a reliable indicator
of the borders between functioning and nonfunctioning wall,
especially in broad akinetic aneurysms.5 In this study period,
with the aid of both preoperative DE-MRI evaluation of the
extent of nonviable scar tissue and intraoperative myocardial
inspection under the beating heart, we used the SAVE pro-
cedure for broad anteroseptal akinesia to exclude as much
scar tissue as possible and to create the elliptical LV shape.14
Finally, quantification of myocardial hyperenhancement
on DE-MRI was measured only at the LV base, because pre-
operative precise determination of the hyperenhancement
area that is not excluded by the operation is often difficult
at the mid to apical LV, especially in patients with broad
anteroseptal scarring. Moreover, inferior and posterior myo-
cardial infarctions usually extend from the basal to the apical
area. Basal myocardial status thus represents extension of in-
farction at circumflex and right coronary artery system. That
may be one explanation why the percentage of fibrosis at the
basal area correlates with postoperative LV function. We
therefore believe that assessment of the basal portion is the
most simple and helpful method of prediction.
CONCLUSION
In conclusion, the amount of LV basal scar tissue affected
LV function and functional recovery after SVR. Patients
with a large amount of LV basal scarring are a high-risk
FIGURE 6. Relationship between latest NewYork Functional Heart Asso-
ciation (NYHA) functional class and percentage of fibrosis. Filled circles in-
dicate patients with recurrent congestive heart failure (CHF). Two of these
patients died, and 2 recovered from New York Heart Association class III to
II after medical treatments.urgery c December 2008
Takeda et al Congenital Heart Diseasegroup. Preoperative assessment of remote myocardial status
with DE-MRI may predict surgical outcomes of patients un-
dergoing SVR.
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